
Ceflik TZ 250mg/31.25mg Injection
Marketer
Brostin Seizz Biocare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ceflik TZ 250mg/31.25mg Injection
Combiflox TZ 250mg/31.25mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration of Combiflox TZ 250mg/31.25mg Injection requires strict medical oversight. Adherence to the prescribed dosage schedule is crucial; incomplete treatment may compromise efficacy. Potential side effects, including nausea, vomiting, diarrhea, and digestive upset, may occur. Worsening side effects necessitate immediate medical consultation. Seek emergency care for allergic reactions like skin rashes, itching, swelling, or breathing difficulties. Prior to commencing treatment, disclose all current medications to your physician. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not affecting driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration support optimal recovery. Your doctor might order tests to monitor the drug's impact on your system.
Uses of Ceflik TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ceflik TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceflik TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceflik TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ceflik TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactam, combined as Ceflik TZ 250mg/31.25mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Ceflik TZ 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Ceflik TZ 250mg/31.25mg injections are typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data in humans, however, remains scarce.
Breast feedingCAUTION
Administering Ceflik TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceflik TZ 250mg/31.25mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceflik TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Ceflik TZ 250mg/31.25mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage changes for Ceflik TZ 250mg/31.25mg Injection are not advised for those with mild or moderately compromised liver function.
What if you forget to take Ceflik TZ 250mg/31.25mg Injection :
Should you inadvertently omit a scheduled dose of Ceflik TZ 250mg/31.25mg Injection, seek advice from your physician.
Facts to Know About Ceflik TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
